D-dimer Testing: An Essential Element in Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Diagnosis
SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism
SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism
The latest technologies from ZEISS help doctors advance ophthalmic care with new ways to see pathology and maximize clinical efficiency and performance
Recent discoveries by researchers at Stanford University has provided new insights into the complex mechanisms of concussion
Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
Testing at the point-of-care improves patient care with results in less than a minute
Stanford researchers have developed a reliable, hassle-free HIV test ideal for screen large numbers of people and heading off potential outbreaks
Study demonstrates that the test can add prognostic information on overall survival
FreeStyle Libre system can eliminate the need for routine fingersticks or any user calibration
Flagship exhibition will be held at the Dubai International Convention & Exhibition Centre, Dubai, UAE in February 2018
A new cost-effective, cloud-based middleware solution helps low-volume laboratories streamline processes and minimize costs
Detecting and minimizing pre-analytical variables in clinical analysis
9 out of 10 CAIS clients surveyed prefer fingerprint drug testing to urine or saliva-based screening
Find out how smooth installation of the Beckman Coulter DxC 700 AU chemistry analyzer helped a busy clinical laboratory to improve patient care
US company will supply point-of-care DPP Zika assays and DPP micro readers under the agreement
Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD